Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Learn effective strategies for planning your retirement in your 40s. Ensure a secure financial future by taking proactive steps now.
11,170 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
FMC Corporation has faced headwinds that can derail even strong portfolios. Here are two words that should make inves...
A quick look at why COEUR Mining stock moved sharply and what it means for investors. This guide breaks down the main...
Chime stock down since its June IPO has traders weighing risk and opportunity. A new $11 million stake from a promine...
Greg Abel's 18-page letter marks a pivotal moment for Berkshire Hathaway. This article breaks down three essential ta...
Biotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
A patient fund manager shows strong conviction, piling another $10 million into Turning Point Brands. The move highli...
The EV market is shifting quickly, and two growth stocks sit at opposite ends of the spectrum: Tesla and Rivian. This...
As inheritance-driven real estate transfers rise, lenders face a new set of conversations with borrowers. A fresh sur...
Palantir stock isn't cheap, but its AI-driven data platform and strong government foothold create a long‑term thesis ...
After a slow season, many sellers paused listings. If 75,000 relistings occur, demand could rise without a flood of n...
A payments stock down draws 30% on growth concerns while a small investor places a $6 million bet as revenue hits $4 ...